ViroGates Press Release

Fri May 18 2018

In a world grappling with rising healthcare costs, ViroGates is stepping up. The innovative medical technology company is fast-tracking its groundbreaking product, suPARnostic®, set to revolutionize patient care prioritization in emergency departments across the globe.

Following rigorous clinical validation and extensive studies involving over 300,000 patients, suPARnostic® is now being trialed in multiple European clinical emergency departments. This diagnostic tool could redefine healthcare.

Addressing the uphill battle of mounting healthcare spending globally, ViroGates empowers healthcare providers. Their tool assists in informed decisions on patient admissions and discharges, optimizing resource allocation within healthcare systems.

To lead the international clinical rollout of suPARnostic®, Dr. Thomas Krarup joins as Vice President of Sales & Marketing. His expertise ensures successful adoption in diverse clinical settings.

In this pivotal commercial phase, ViroGates explores diverse funding avenues. The goal? To fully unleash suPARnostic® in transforming patient care and resource distribution.

In conclusion, ViroGates pioneers healthcare innovation with suPARnostic®. This breakthrough technology reshapes patient care prioritization in emergency departments. With advanced diagnostics, the company paves the way for effective resource allocation globally. Dr. Thomas Krarup’s appointment and strategic funding efforts highlight ViroGates’ commitment to revolutionizing patient care.

For more information, please see Press Release here

For yderligere information, se Pressemeddelelsen her

Please find the Danish article in MedWatch “Biotekselskab fra Birkerød ruller blodtest ud på europæiske hospitaler” here


published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution


For Automated Systems


Clinical and Research

suPARnostic POC+


Point-of-care finger prick

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar


Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates